The prognostic factor for outcome following second resection for intrahepatic recurrence of hepatocellular carcinoma with a hepatitis B virus infection background

被引:26
|
作者
Sun, HC
Tang, ZY [1 ]
Ma, ZC
Qin, LX
Wang, L
Ye, QH
Fan, J
Wu, ZQ
Zhou, XD
机构
[1] Fudan Univ, Liver Canc Inst, Shanghai 200032, Peoples R China
[2] Fudan Univ, Zhong Shan Hosp, Shanghai 200032, Peoples R China
关键词
hepatocellular carcinoma; recurrence; second resection;
D O I
10.1007/s00432-004-0645-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Second resection has been proved to be a safe and effective treatment for patients with intrahepatic recurrent HCC after primary resection; however, preoperative prognostic factors for outcome following second resection in patients with a hepatitis B virus (HBV) infection background remains to be clarified. Methods: Fifty-seven patients with intrahepatic recurrent an HCC and HBV infection background received second resection from 1997 to 2003 in our institute. All of them were negative for anti-hepatitis C virus (HCV) and positive regarding HBV profile. Patient and tumor factors were analyzed. Results: At the time of preparing this paper, 31 had re-recurrence and 21patients had died. No postoperative mortality was noted. The 1-, 3-, and 5- year overall survival after second resection were 69.9 %, 61.2 %, and 30.6 %, respectively. Univariate and multivariate analysis showed that vascular invasion and time to recurrence were the independent prognostic factors for overall survival following second resection. The 3- and 4-year overall survival after second resection were 57.7 % and 46.6 % in patients with the presence of any of two risk factors (n = 46), and 100 % and 100 % in those with absence of both risk factors (n = 11, P = 0.008). Conclusions: Vascular invasion and time to recurrence were the prognostic factors for overall survival following second resection of intrahepatic recurrent HCC.
引用
收藏
页码:284 / 288
页数:5
相关论文
共 50 条
  • [1] The prognostic factor for outcome following second resection for intrahepatic recurrence of hepatocellular carcinoma with a hepatitis B virus infection background
    Hui-Chuan Sun
    Zhao-You Tang
    Zeng-Chen Ma
    Lun-Xiu Qin
    Lu Wang
    Qin-Hai Ye
    Jia Fan
    Zhi-Quan Wu
    Xin-Da Zhou
    Journal of Cancer Research and Clinical Oncology, 2005, 131 : 284 - 288
  • [2] Impact of Hepatitis B Virus Infection on Outcome Following Resection for Intrahepatic Cholangiocarcinoma
    Zhang, Lei
    Cai, Jian-Qiang
    Zhao, Ian-Jun
    Bi, Xin-Yu
    Tan, Xiao-Gang
    Yan, Tao
    Li, Cong
    Zhao, Ping
    JOURNAL OF SURGICAL ONCOLOGY, 2010, 101 (03) : 233 - 238
  • [3] Hepatitis B virus infection: A favorable prognostic factor for intrahepatic cholangiocarcinoma after resection
    Zhou, Hua-Bang
    Wang, Hui
    Li, Yu-Qiong
    Li, Shuang-Xi
    Wang, Hao
    Zhou, Dong-Xun
    Tu, Qian-Qian
    Wang, Qing
    Zou, Shan-Shan
    Wu, Meng-Chao
    Hu, He-Ping
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (10) : 1292 - 1303
  • [4] Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence
    Chan, Kun-Ming
    Tsai, Chun-Yi
    Yeh, Chun-Nan
    Yeh, Ta-Sen
    Lee, Wei-Chen
    Jan, Yi-Yin
    Chen, Miin-Fu
    BMC GASTROENTEROLOGY, 2018, 18
  • [5] Hepatitis B virus surface antigen-negative and hepatitis C virus antibody-negative hepatocellular carcinoma Clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence after resection
    Li, Tao
    Qin, Lun-Xiu
    Gong, Xiao
    Zhou, Jian
    Sun, Hui-Chuan
    Qiu, Shuang-Jian
    Ye, Qing-Hai
    Wang, Lu
    Fan, Jia
    CANCER, 2013, 119 (01) : 126 - 135
  • [6] Prognostic Impact of MAFLD Following Surgical Resection of Hepatitis B Virus-Related Hepatocellular Carcinoma: A Nationwide Cohort Study
    Yun, Byungyoon
    Ahn, Sang Hoon
    Oh, Juyeon
    Yoon, Jin-Ha
    Kim, Beom Kyung
    CANCERS, 2022, 14 (20)
  • [7] Relationship of hepatitis B virus infection to the recurrence of hepatocellular carcinoma after direct acting antivirals
    Shimizu H.
    Matsui K.
    Iwabuchi S.
    Fujikawa T.
    Nagata M.
    Takatsuka K.
    Tanemura H.
    Nakazaki H.
    Nakano M.
    Watanabe T.
    Indian Journal of Gastroenterology, 2017, 36 (3) : 235 - 238
  • [8] Different intrahepatic recurrence rate after resection of hepatocellular carcinoma associated with chronic hepatitis B and C
    Nagasue, N
    Ohmori, H
    Yamanoi, A
    Dhar, DK
    El-Assal, ON
    Yamamoto, A
    HEPATOLOGY RESEARCH, 1998, 12 (02) : 93 - 110
  • [9] Prognostic impact of hepatitis B virus infection in patients with intrahepatic cholangiocarcinoma
    Ahn, Chul-Soo
    Hwang, Shin
    Lee, Young-Joo
    Kim, Ki-Hun
    Moon, Deok-Bog
    Ha, Tae-Yong
    Song, Gi-Won
    Lee, Sung-Gyu
    ANZ JOURNAL OF SURGERY, 2018, 88 (03) : 212 - 217
  • [10] Role of antiviral therapy in reducing recurrence and improving survival in hepatitis B virus-associated hepatocellular carcinoma following curative resection
    Zuo, Chaohui
    Xia, Man
    Wu, Qunfeng
    Zhu, Haizhen
    Liu, Jingshi
    Liu, Chen
    ONCOLOGY LETTERS, 2015, 9 (02) : 527 - 534